I assume low dose Bisantrene would be taken by patients with high risk factors in much the same way statins are taken for cholesterol treatment. If this is the case then Bisantrene will have big pharma falling over each other to secure RAC.
I assume low dose Bisantrene would be taken by patients with...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.145(9.35%) |
Mkt cap ! $277.8M | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.75 | $1.61 | $627.3K | 374.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2862 | $1.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 710 | 1 |
View Market Depth
| Last trade - 15.36pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.67 |
Change
0.145 ( 8.61 %) |
||||
| Open | High | Low | Volume | ||
| $1.64 | $1.73 | $1.63 | 33428 | ||
| Last updated 15.54pm 14/05/2024 ? | |||||
| RAC (ASX) Chart |